A recent study indicates that patients who come off blockbuster slimming jabs like Wegovy and Mounjaro tend to recover reduced body mass at a significantly accelerated pace than those who end traditional lifestyle plans.
Findings released in a leading health publication shows that while overweight individuals frequently drop substantial amounts of their total mass while undergoing treatment, the mass comes back at an estimated rate of 0.8 kg per month after stopping.
"Individuals buying these treatments should be aware of the potential of quick rebound weight gain when the therapy is stopped," cautioned researcher Dr. Susan Jebb.
This pace of regain means a reversion to pre-treatment mass in about one and a half years.
Weighing Treatments
The study, which reviewed 37 of trials involving thousands of participants, contrasted the effects of the injectable medications with older methods.
Scientists point out that individuals who shed pounds through lifestyle changes alone generally see a more gradual weight regain—approximately 0.1 kg a month—once they finish.
Explaining the Quick Rebound
Nutrition scientists believe the way of the jabs accounts for the accelerated regain.
The injections mimic a natural hormone called glucagon-like peptide-1, which helps regulate hunger.
"Artificially providing GLP-1 concentrations far above than the body's typical production might result in the body to produce less of its endogenous GLP-1, and may also reduce sensitivity to its effects," noted Dr. Adam Collins, a dietetics researcher.
"Discontinuation of this hormone supplement leads to hunger is uncontrolled, making overeating a significant risk."
An Ongoing Issue?
Medical guidelines suggest the injections for individuals with obesity-related medical conditions, alongside recommended diet and exercise modifications.
A number of clinicians say that, considering the significant potential of relapse, the therapy is often long-term.
This view is echoed by pharmaceutical companies, who note that the results "highlight the chronic character of excess weight," akin to managing diseases like diabetes.
Patient Testimonies
Individuals who have discontinued the medication explain a intense resurgence of cravings.
"It was like a trigger flipping and you're instantly starving," said a patient.
The struggle is exacerbated if patients have not developed sustainable dietary or behavioural modifications during therapy.
Significant Interest
Figures suggest that a significant number of people in the UK have tried these injections in the last 12 months, with interest remaining high.
- Use is higher among women than men.
- The middle-aged age group shows the highest level of interest.
- Many access the drugs through private healthcare rather than public health services.
In conclusion, researchers caution that while these medications are effective agents for shedding pounds, they are not a standalone fix and lasting health benefits hinges on integrated behavioural management.
